Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancerOLIVEIRA, Carla; VELHO, Sérgia; DOMINGO, Enric et al.Oncogene (Basingstoke). 2005, Vol 24, Num 51, pp 7630-7634, issn 0950-9232, 5 p.Article

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTCSOARES, Paula; TROVISCO, Vitor; ROCHA, Ana Sofia et al.Oncogene (Basingstoke). 2003, Vol 22, Num 29, pp 4578-4580, issn 0950-9232, 3 p.Article

Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarrayREIS-FILHO, Jorge S; SIMPSON, Pete T; MARTINS, Albino et al.Virchows Archiv. 2003, Vol 443, Num 2, pp 122-132, issn 0945-6317, 11 p.Article

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressivenessTROVISCO, Vitor; SOARES, Paula; MAGALHAES, Joao et al.Virchows Archiv. 2005, Vol 446, Num 6, pp 589-595, issn 0945-6317, 7 p.Article

Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapyPRETO, Ana; SINGHRAO, Sim K; HAUGHTON, Michele F et al.Oncogene (Basingstoke). 2004, Vol 23, Num 23, pp 4136-4145, issn 0950-9232, 10 p.Article